ADXS Projected Dividend Yield

Ayala Pharmaceuticals Inc ( OTCBB : ADXS )

Ayala Pharmaceuticals is a clinical-stage biotechnology company focused on the development and commercialization of proprietary Listeria monocytogenes (Lm) Technology antigen delivery products based on a platform technology that utilizes live attenuated Lm bioengineered to secrete antigen/adjuvant fusion proteins. Co.'s pipeline of product candidates include: ADXS-503, which is for the cancer indication of non-small cell lung cancer in combination with KEYTRUDA® (pembrolizumab); ADXS-504, which is for the cancer indication of early stage prostate cancer; and ADXS-PSA, which is for the cancer indication of metastatic prostate cancer in combination with KEYTRUDA® (pembrolizumab).

10 YEAR PERFORMANCE RESULTS

ADXS Dividend History Detail
ADXS Dividend News
ADXS Competitors News

# of Shares: 0

Closing Price: 0.60

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2026	0.00	0%	0	$ 0.00	0.00%
2027	0.52	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.52 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.52 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
2026	Feb 03, 2026	Mar 09, 2026	Feb 03, 2026	Mar 06, 2026	0.5200
2026 Total:					0.5200